The stable, regulated and tissue-specific expression of a therapeutic transgene can be best achieved by the transfer of a complete genomic locus, which will include the shortand long-range regulatory elements that are critical for the accurate control of gene expression. However, when techniques that rely on the random integration of exogenous DNA into the human genome are used for gene transfer, the risk of insertional mutagenesis remains a major issue. Using components derived from the adeno-associated virus (AAV), we have successfully targeted the integration of 200 kb bacterial artificial chromosomes containing the entire b-globin locus into the AAVS1 site on human chromosome 19. We show that transient expression of the AAV Rep proteins in K562 cells facilitated site-specific transgene integration in 17% (6 of 36) of all analysed integration sites. Southern blot analysis revealed the locus had integrated into AAVS1 as an intact, functional unit in five of the six clones generated. Furthermore, each of the site-specific integrants exhibited sustained and appropriately regulated transgene gene expression over a period of 8 months of continuous culture in the absence of selective pressure. We anticipate that the approach developed in this study may be suitable for facilitating targeted integration of intact genomic loci in adult and embryonic stem cells, and therefore provide a powerful tool not just for functional studies but in establishing model systems for the ex vivo correction of genetic disorders.
Introduction
Despite the 30 years that have passed since gene therapy was first proposed, the transfer of genes into higher organisms to cure disease remains an enormous technical challenge. Viral vectors remain the most popular vehicle of choice in gene therapy trials because of their efficiency in gene transfer in mammalian cells. However, viral vectors typically accept relatively short DNA sequences, and therefore are often used with human cDNA sequences driven by heterologous viral promoters. Transgene expression from such vectors may be inappropriately regulated, and is susceptible to transcriptional silencing and positional effects. 1, 2 In addition, the design of viral-based constructs that mimic or reproduce natural physiological control mechanisms is exceptionally difficult, especially when many of the complex mechanisms involved in the regulation of gene expression have yet to be fully elucidated. Conceptually, the simplest alternative is to deliver a therapeutic gene as a native genomic construct, including all the short-and long-range cis-acting regulatory elements that are critical for the accurate control of gene function.
Bacterial artificial chromosome (BAC) vectors can incorporate transgenes up to several hundred kb in size, large enough to contain the full sequence of the majority of human genomic loci, most of which are between 27 and 72 kb with just 4% larger than 140 kb. 3 Numerous studies using BACs containing intact genomic loci have demonstrated cell-specific, physiologically regulated gene expression as well as synthesis of the full spectrum of isozymic forms of a protein derived from a given locus. [4] [5] [6] [7] [8] [9] However, as for smaller recombinant transgenes, BAC vectors often integrate randomly into the genome of the recipient cell. This can lead to several undesirable side effects, including insertional mutagenesis, cell transformation or variable expression of the BAC transgene. The development of ex vivo gene transfer systems that facilitate the targeted integration of an intact genomic locus to specific sites in the host genome would be of significant importance and would represent a powerful approach to correction of gene dysfunction in various inherited and acquired disorders.
One method to achieve this would involve the use of components derived from adeno-associated virus (AAV). AAV is a non-pathogenic parvovirus that has evolved a unique ability to integrate specifically at a defined site, AAVS1, on human chromosome 19 (19q13.4) . [10] [11] [12] [13] The AAV genome is a single-stranded DNA of 4.7 kb consisted of two open reading frames, REP and CAP, flanked by palindromic sequences, termed the inverted terminal repeats (ITRs). The ITRs are required for viral replication, packaging and integration [14] [15] [16] and contain binding sites for the Rep proteins, termed Rep-binding elements (RBEs). 17, 18 An RBE has also been identified within the p5 promoter. 19 The large Rep proteins, Rep68 and Rep78, mediate site-specific integration by binding to the RBEs located within the AAV genome and the AAVS1 site. 20, 21 It is thought that the Rep protein/DNA complex localizes to the AAVS1 site before a nonhomologous recombination event takes place resulting in site-specific integration of the AAV genome. [22] [23] [24] [25] A large number of studies have reported targeted transgene integration into the AAVS1 site. One of the most common approaches involves the co-transfection of human cells with two separate DNA plasmids, one containing a transgene flanked by ITRs and the other containing a Rep expression cassette. [26] [27] [28] [29] [30] More recently a 138 bp region that encompasses the entire p5 promoter, termed the p5 integration efficiency element (p5IEE), has also been shown to mediate Rep-dependent site-specific integration at AAVS1 in cis. 31, 32 However, these studies have used relatively small DNA plasmids as integrants, generally o10 kb in size.
In this study we describe a method to facilitate the site-specific integration of 4200 kb BAC vectors that contain the entire human b-globin locus. These BAC vectors were modified to contain the AAV-derived p5IEE, as well as the enhanced green fluorescent protein (EGFP) and dsRed reporter genes under the control of different globin-specific promoters. Following co-transfection with Rep mRNA in K562 cells, we demonstrate site-specific integration of the BAC transgene into the AAVS1 site on chromosome 19 in 6 of 36 (B17%) of the clonal cell lines generated. After the continuous culture of the six clonal cell lines in the absence of antibiotic selection, a remarkable stability and uniformity in reporter gene expression from the BAC transgene was observed.
Results
Transient Rep68/78 protein expression following transfection of mRNA Because the persistent overexpression of Rep proteins in human cells has been reported to cause cytotoxic and cytostatic effects, 33, 34 an mRNA transfection approach was used to achieve transient expression of Rep68/78 proteins in the human erythroleukaemic cell line K562. In vitro transcribed, capped and polyadenylated mRNA coding for the Rep68 or Rep78 protein was generated and subsequently electroporated into K562 cells. As a control, K562 cells were also transfected with either the pHIV68 or pRep10 plasmid, which contains Rep68 and Rep78 expression cassettes, respectively. Cells were harvested at 24 h and stained with a Rep-specific antibody and fluorescently labelled secondary antibody.
Using fluorescent microscopy, Rep protein expression could be detected in the nuclei of485% of cells transfected with Rep68 or Rep78 mRNA (Figure 1a ). In comparison, Rep protein expression was detected in o50% of cells 24 h after the electroporation of the pHIV68 and pRep10 plasmids. Furthermore, mRNA electroporation resulted in improved cell viability compared with plasmid electroporation (Figure 1b ) and the proportion of viable cells after electroporation with Rep mRNA was not significantly different from mockelectroporated cells. These results suggest that the electroporation of K562 cells with Rep68/78 mRNA is an effective, non-toxic approach to achieve transient expression of Rep68/78 proteins in human cells.
Expression of Rep68/78 mRNA enhances efficiency of DNA integration Three BAC vectors containing modified versions of the human genomic b-globin locus as well as the AAVderived p5IEE, termed G g-A gEGFP-p5, A gRedbEGFP-p5 and G gRedbEGFP-p5 (Figure 2 ), were each co-electroporated with 20 mg of Rep68/78 mRNA into K562 cells. As a control, K562 cells were transfected with each of the three BAC constructs without Rep mRNA. Following each electroporation, transfection efficiency was assessed by flow cytometry 24 and 48 h post-transfection to identify cells positive for EGFP or dsRed reporter gene expression. Rep68/78 expression was shown to have no significant effect (P40.52) on the transfection efficiency of each of the three BAC constructs (Figure 3a) . After the addition of hygromycin 2 days post-transfection, 100 cells per well were seeded in five 96-well plates to establish clonal cell lines for each transfection experiment. The resulting clones were then expanded in the absence of hygromycin over a period of 4 weeks to promote loss of any plasmid DNA that had not integrated but was persisting episomally.
Hygromycin selection was then added for a further 2 weeks before the number of clonal cell lines was assessed. A total of 335 ± 45 hygromycin-resistant clones were established following the co-transfection of BAC DNA with Rep mRNA, whereas 121 ± 24 clones were established following the transfection of K562 cells with BAC DNA alone (Figure 3b ), corresponding to an approximately threefold increase in the frequency of colony formation when BAC DNA was co-electroporated with Rep mRNA. As no significant difference in transfection efficiency was observed between co-transfected cells and cells transfected with BAC vectors alone, this suggests that Rep68/78 expression in K562 cells enhances the frequency of BAC integration.
Fluorescence in situ hybridization to detect site-specific integration of b-globin locus at chromosome 19
For each of the six electroporations described above, 12 stably transfected clonal cell lines were selected for fluorescence in situ hybridization (FISH) analysis to determine whether site-specific integration of the BAC transgene could be demonstrated. This was performed using a probe specific to the b-globin locus and a second probe specific to a 169 kb genomic region (BAC clone RP11-463M24) containing the entire human AAVS1 site and surrounding sequences. Co-localization of the two probes was assessed on metaphase chromosomes as well as inter phase cell nuclei.
Targeted integration of the full-length b-locus SE Howden et al Insertion of the BAC into various chromosomes in the karyotype was observed in all 36 clones resulting from the transfection of K562 cells with BAC DNA alone, but no integrations were observed on chromosome 19, and there was no co-localization between the b-globin BAC and the BAC probe spanning the AASV1 site (Figures 4a  and b) . In the absence of Rep68/78 mRNA, we conclude that DNA integration into the host cell genome had occurred randomly. In comparison, co-localization of the b-globin BAC-specific and AAVS1-specific probes was observed in 7 (19.4%) out of the 36 analysed clones that had resulted from the co-transfection of BAC DNA and Rep68/78 mRNA. However, in one case, the co-localized probes were not on chromosome 19, suggesting that a translocation event had occurred in this clone. This clone was excluded from further analysis.
Overall, six independent clones were identified to contain targeted integration of the b-globin locus at the AAVS1 locus on chromosome 19 (Table 1 ). In each of these six clonal cell lines, co-localization of the two probes was consistently seen on one arm of a small metacentric chromosome corresponding to chromosome 19 ( Figure 4c ). Co-localization of the two probes in interphase nuclei suggests that they are located less than 50 kb apart. 35 However, we consistently observed total overlap of the plasmid with the BAC probe, suggesting Targeted integration of the full-length b-locus SE Howden et al insertion of the plasmid into the region covered by the RP11-463M24 BAC (Figure 4d ). Further evidence indicating that the integration of the globin locus had occurred into or very close to the AAVS1 site was provided by FISH studies of DNA chromatin fibres from cells containing an integration site that was co-localized to RP11-463M24. In these preparations, chromatin fibres containing junctions between the probes specific for the b-globin locus and RP11-463M24 BAC were observed (Figure 4e ).
Southern blot analysis
Southern blot analysis was performed on the site-specific integrants (clones 1-6) to determine whether the b-globin locus had integrated into AAVS1 as an intact sequence. This was achieved by digesting the total genomic DNA from each clone with the SfiI restriction endonuclease followed by hybridization with an EGFP-specific probe. SfiI recognition sites are positioned at the 5 0 end of the b-globin locus control region (LCR) and just downstream of the EGFP reporter gene (Figure 5a ). The SfiI digestion of G g-A gEGFP-p5 releases a 42 kb fragment containing the LCR, e and EGFP genes. Following SfiI digestion of A gRedbEGFP-p5 and G gRedbEGFP-p5 a 69 kb fragment that spans the LCR, e, g, dsRed, d and EGFP genes is released. Southern blot analysis of clones 1 and 2, which contain the G g-A gEGFP-p5 construct, showed a single band that co-migrated with the 42 kb band in the control lane that contained Figure  5b ). Similarly, a single band was observed following analysis of clones 3, 5 and 6, corresponding to the 69 kb band that was observed in the control lanes containing SfiI-digested A gRedbEGFP-p5 or G gRedbEGFP-p5 DNA. A single band was also observed for clone 4; however, this migrated somewhat slower and was therefore larger in size with respect to the normal 69 kb band. It is possible that, prior to integration of the b-globin locus in this clone, a break point may have occurred somewhere between the LCR and EGFP genes. Alternatively, this upshifted band may be the result of a rearrangement.
Transgene copy number
Semiquantitative polymerase chain reaction (PCR) analysis was performed to estimate the transgene copy number in each of the clones identified that contain the b-globin locus site-specifically integrated into the AAVS1 site on human chromosome 19. A competitive PCR was performed on the chromosomal DNA isolated from Targeted integration of the full-length b-locus SE Howden et al clones 1-6 using primers specific for the EGFP and b-globin genes. The relative intensity of the EGFP-specific PCR product was compared to the b-globin-specific PCR product for each of the transgenic cell lines using computer software (Quantity One; Bio-Rad, Hercules, CA, USA) and capillary electrophoresis (Bio-Rad), where a good correlation in DNA quantitation was observed. The G g-A gEGFP-p5 construct was used as a DNA template in a control reaction, as this is known to contain single copies of both the EGFP and b-globin genes. For the control reaction, an approximately 1:1 ratio of EGFP:b-globin PCR product was observed, indicating that amplification of the two products occurs with equal efficiency ( Figure 6 ). Following the PCR analysis of clones 1 and 2, an approximately 1:4 ratio of EGFP: b-globin PCR product was observed, indicating the presence of one copy of the EGFP gene for every four A total of 12 colonies were screened for each group, however one of these clones (in the G gRedbEGFG-p5+Rep group) showed colocalization of the AAVS1 and BAC-specific probes, but this was not observed on chromosome 19. This clone was excluded from the overall analysis.
Targeted integration of the full-length b-locus SE Howden et al copies of the b-globin gene. This is the expected ratio for clones carrying a single copy of the G g-A gEGFP-p5 BAC (one copy of the EGFP transgene+one copy of the b-globin transgene+three endogenous copies of the b-globin gene). PCR analysis of clones 3 and 4 revealed an approximately 1:3 ratio of EGFP:b-globin PCR product, whereas for clones 5 and 6, ratios of approximately 2:3 and 1:1 were obtained respectively. As clones 3-6 were generated using the dual reporter constructs, which contain a dsRed reporter gene in place of the b-globin gene, only the three endogenous b-globin genes should be present in these clones. Therefore, we can infer that clones 3 and 4 are likely to contain single copies of the A gRedbEGFP-p5 BAC, whereas clones 5 and 6 are likely to contain 2 and 3 copies of the G gRedbEGFP-p5 BAC respectively.
Reporter gene expression
Reporter gene expression was routinely monitored in the transgenic cell lines carrying modified versions of the b-globin locus targeted to chromosome 19. All six clones were cultured continuously in the absence of antibiotic selection and reporter gene expression was assessed on a monthly basis by flow cytometry. In clones 1 and 2, which contain G g-A gEGFP-p5, EGFP expression was detected in 495% of cells over an 8-month period of continuous culture (Figures 7a and c) . dsRed reporter expression (driven from the A g promoter) could be detected in 70-85% of cells following monthly flow cytometric analysis of clones 3 and 4, which contain the A gRedbEGFP-p5 transgene. On the other hand, in clones 5 and 6, which contain the G gRedbEGFP-p5 transgene,495% of cells expressed the dsRed reporter (driven from the G g promoter) (Figures 7b and c) . Only slight variations in the level of reporter gene expression were observed over time.
Reporter gene expression was extremely uniform and persisted in all six clones over a period of 8 months in the absence of antibiotic selection. EGFP reporter gene expression was also observed in clones 3-6, although this was detected in a smaller fraction (1-40%) of the total cell population. The level of EGFP expression was also extremely low when compared to that in clones 1 and 2. As EGFP expression is driven from the b-globin promoter in clones 3-6, rather than the g-globin promoter as in clones 1 and 2, this is in line with the embryonic phenotype of globin gene expression observed in K562 cells. 36, 37 Treatment with either hemin (0-50 mM) or cisplatin (0-15 mM) also caused a significant dose-dependent shift in the level of EGFP expression in clones 1-2, with a similar increase in the level of dsRed expression observed for clones 3-6 (Figures 7d and e) . Overall, hemin was more effective in inducing reporter gene expression in all six clones, with clone 6 showing the highest level of reporter gene induction for both compounds. Interestingly, clone 6 is also thought to contain the most copies of the BAC transgene, which may suggest an association between the level of reporter gene induction and transgene copy number. No significant increase in the level of EGFP expression was observed for clones 3-6 (data not shown) suggesting that neither compound has an effect on b-globin promoter activity.
Discussion
The regulation of gene expression is immensely complex, with many genes exhibiting tissue specificity, alternative splicing, responses to gradients of cellular signals, and ε β δ Figure 6 Quantitative PCR to determine transgene copy number. A competitive PCR was performed on the genomic DNA extracted from clones 1-6 using primers specific for the b-globin and EGFP genes. The G g-A gEGFP-p5 construct, which contains single copies of both the EGFP and b-globin genes was used in a control reaction. The PCR products were visualized following gel electrophoresis and band intensities were quantitated using computer software (Quantity One; Bio-Rad). For the control reaction an approximately 1:1 ratio of EGFP: b-globin PCR product was observed, indicating equal amplification of both products. The BAC copy number in each of the transgenic cell lines was estimated by comparing the relative intensity of the EGFP-specific PCR product to the b-globin-specific PCR product. The approximate ratio of EGFP: b-globin PCR product is indicated for each clone.
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Targeted integration of the full-length b-locus SE Howden et al other subtle controls. Studies that rely on the expression of cDNA sequences after gene transfer are often associated with transcriptional silencing, positional effects and unregulated or low levels of transgene expression. It is increasingly apparent that the transfer of a complete genomic locus is more likely to produce physiological levels of sustained, tissue-specific transgene expression. Generally this can only be achieved following integration of the transgene locus into the host genome. When this occurs randomly, however, deleterious mutations at the site of integration, cell transformation and/or variable levels of transgene expression may result.
We have recently reported the use of components derived from AAV to facilitate the site-specific integration of a 21 kb BAC vector in K562 cells. 38 As this method utilizes non-viral gene transfer systems, which in principle are not size restricted, we hypothesized that this approach could be used to facilitate the targeted integration of an entire genomic locus. In this study, 200 kb BAC vectors containing the full-length human b-globin locus, tagged with the dsRed and/or EGFP reporter genes, were modified to contain the AAVderived p5IEE. The p5IEE was first characterized by Philpott et al., 31 and has been shown to be the only cis element required to target a substrate DNA for sitespecific integration to the AAVS1 site. Moreover, in comparison to ITR-mediated integration, the p5IEE is 10-to 100-fold more effective at inducing integration than the AAV ITR.
The p5IEE-modified BAC vectors were co-transfected with Rep mRNA in K562 cells, an erythroleukaemic cell line that predominately expresses foetal haemoglobin. Although Rep mRNA was shown to have no effect on BAC transfection efficiency, an approximately 2.7-fold increase in the generation of hygromycin-resistant clonal cell lines was observed when BAC DNA was cotransfected with Rep mRNA as compared with the transfection of BAC DNA in K562 cells alone. This is consistent with previous studies demonstrating that plasmids containing RBEs integrate into the genome at a significantly higher frequency in cells expressing Rep, compared to cells that do not express Rep proteins. 26, 38 As the constructs used in this study contain elements from Epstein-Barr virus (EBV) (oriP and EBNA1), which are known to facilitate the replication and episomal persistence of plasmid DNA in human cells, an extrachromosomal state of the transfected plasmid cannot be completely excluded. However, in their episomal form, these constructs are rapidly lost in dividing cells in the absence of selection. Thus, prior to analysis, the clonal cell lines established in this study were expanded over a period of 4 weeks in the absence of selection to promote loss of any plasmid DNA that was persisting episomally. Importantly, only a single plasmid-specific signal could be detected in all cells analysed by FISH, which was consistently seen in the same chromosomal region in multiple cells within each clone. This is in direct contrast to non-integrated EBV-based plasmids persisting episomally, which are known to bind to chromosomes in a more or less random fashion and are usually present in multiple copies per cell. Therefore, it is highly likely that integration of the BAC transgene had occurred in each of the clones selected for analysis.
Using FISH analysis, integration of the b-globin transgene within the AAVS1 region on chromosome 19 was observed in approximately 17% (6 of 36) of clones that had resulted from the co-transfection of the b-globin BACs and Rep mRNA. In one additional case, colocalization of the BAC-and AAVS1-specific probes was observed on a larger chromosome, suggesting that a translocation event had occurred in this clone. It is not known whether this event occurred before or after transgene integration, or whether the integration event itself may have caused the translocation event. Southern blot analysis was performed to assess the integrity of the b-globin BACs that had integrated site specifically in the six clones identified by FISH. Analysis of the DNA sequences between the LCR and the EGFP reporter gene revealed a single band of the correct size in five clones, indicating that the b-globin locus is intact and has integrated within the AAVS1 without any major rearrangements.
A remarkable stability and uniformity in reporter gene expression was also observed from the b-globin BACs in each of the six site-specific integrants identified. Importantly, this has been maintained in all six clones over 7-8 months of continuous culture in the absence of selection. Upon comparison of the two clones generated from each of the three b-globin BACs, a high similarity in the profile of reporter gene expression was also noted. Together these data provide strong evidence that the AAVS1 site is a transcriptionally active region of the genome and that targeting a complete genomic locus to this site can permit long-term and appropriately regulated transgene expression while eliminating variations in expression that might arise from positional integration effects.
A significant increase in reporter gene expression was observed in all six clones following treatment with hemin and cisplatin, each of which are known inducers of g-globin gene expression in K562 cells. In previous studies conducted by our group, hemin and cisplatin have been shown to induce g-globin gene expression while having a minimal effect on b-globin gene expression K562 cells. 39, 40 Importantly, following induction of the clonal cell lines carrying the dual reporter constructs, a significant increase in dsRed expression driven by the A g and G g globin promoters was observed, whereas expression from the b-globin promoter consistently produced low levels of EGFP. This result provides further evidence that the transgene expression from the AAVS1-integrated b-globin locus mirrors the expected developmental, stage-specific, globin gene expression profile of normal K562 cells. We anticipate that the clones generated in this study may be used to detect and evaluate compounds with the therapeutic potential to specifically upregulate globin chain synthesis, enabling a rational approach to drug design for the treatment of haemoglobinopathies such as b-thalassemia and sickle cell disease.
In many of the previous studies that demonstrate targeted transgene integration into AAVSI, relatively small DNA constructs (usually o10 kb in size) were used. In a more recent study, however, Oehmig el al. 41 reported the site-specific integration of an HSV/AAV hybrid vector containing a 133 kb genomic fragment that encoded the entire b-galactosidase gene. Although the authors report a high level of sustained transgene expression from the clones exhibiting AAVS1-specific integration, the integrity of the genomic locus was not assessed and therefore it is unclear whether the entire locus had integrated as an intact unit and without any major rearrangements. The rep gene was also included in the targeting vector, and although this was located adjacent to the ITR-flanked transgene, PCR analysis revealed the presence of rep sequences in450% of the clones that were identified as positive for site-specific integration of the b-galactosidase transgene. This may be problematic, as continual Rep protein expression can have cytotoxic effects 33 and may lead to chromosomal instability and/or mobilization of the transgene. 42 In this study cells were transfected with Rep mRNA, which enabled transient expression of the Rep proteins while minimizing the problems that may arise following integration of rep coding sequences in the host genome. The method described here also relies on the use of nonviral gene delivery systems, which, unlike viral vectors, have a practically unlimited capacity for DNA. Therefore, this approach can potentially be used to facilitate the site-specific integration of DNA fragments that are hundreds of kilobases in size, including any genomic Targeted integration of the full-length b-locus SE Howden et al fragment existing within BAC library clones or even constructs encoding multiple gene loci. Unfortunately one of the major drawbacks with this system is that it is largely limited to cells in culture and would be difficult to apply in vivo with any real efficacy. However, it may be suitable for the transfer of a complete genomic locus in primary human cells, such as adult and embryonic stem cells. This offers a powerful tool for functional studies and the creation of model systems, and also addresses a significant problem in gene therapy, the achieving of appropriately regulated transgene expression in a way that avoids the risks associated with random DNA integration.
Materials and methods
Vector construction
The BAC clone pEBAC148b contains the entire b-globin locus as a 185 kb genomic insert in a second-generation PAC/BAC cloning vector and has previously been described. 43 Versions of this BAC clone, G g-A g-EGFP and b-EGFP, which contain the EGFP reporter gene in place of either the g-globin or b-globin genes respectively, have also been previously described. 39, 44 In this study, b-EGFP was modified further by replacing the G g-or (Figure 2 ). Plasmids were propagated in the E. coli strain DH10B (Invitrogen, Chadsworth, CA, USA) and purified using standard alkaline lysis procedures followed by CsCl-ethidium bromide density gradient centrifugation.
In vitro transcription of Rep mRNA
The Rep68 coding region was amplified by PCR from pHIV68 (provided by Jude Samulski, University of North Carolina, Chapel Hill, NC, USA) using primers 5 0 -CAT-ACGATTTAGGTGACACTATAGAATACAGTGAGCAC GCAGGGTCTC-3 0 and 5 0 -TTTTTTTTTTTTTTTTTTTTT TTTTTTTTTCCTTGTCGAGTCCGTTGAAG-3 0 that contain a 5 0 SP6 promoter sequence and a 5 0 Poly(T) tract respectively. The Rep78 coding region was amplified from pRep10 (provided by Horace Drew, CSRIO, North Ryde, NSW, Australia) using primers 5-CATACGAT TTAGGTGACACTATAGAATACAGGCTCGACAATTGA CTAGTG-3 0 ) 5 0 -TTTTTTTTTTTTTTTTTTTTTTTTTTTT TTCTCGAGATTACCCTGTTATC-3 0 that contain a SP6 promoter and poly(T) tract. Both PCR products were column purified (Qiagen, Chatsworth, CA, USA) and used as templates to generate 5 0 m7GpppG-capped and polyadenylated mRNA encoding the Rep68 and Rep78 proteins using the SP6 mMessage mMachine in vitro 
Cell culture
The human eyrthroleukaemic cell line K562 was maintained in continuous culture in Dulbecco's modified Eagle's medium (DMEM), supplemented with 10% fetal calf serum (FCS) and 2 mM L-glutamine. Cells were incubated at 37 1C in a humidified atmosphere supplemented with 5% CO 2 .
Transfection
Cells were washed twice with OptiMEM (Invitrogen, Chadsworth, CA) and resuspended at a concentration of 10 7 cells per ml. Cell suspension (0.5 ml) was mixed with 8 mg BAC DNA with or without 20 mg of in vitro transcribed mRNA (10 mg Rep68 mRNA+10 mg Rep78 mRNA) and electroporated in a 0.4 cm cuvette using a Bio-Rad gene pulser (Bio-Rad) with the following parameters: resistance, N; capacitance, 25 mF; charge, 220 V. DMEM (20 ml) supplemented with 10% FCS was then added to the cell suspension and the cells were incubated at 37 1C in a humidified atmosphere supplemented with 5% CO 2 . Hygromycin (200 mg ml
À1
) was added to the culture media two days post-transfection and cells were seeded in 96-well plates (100 cells per well) to establish stably transfected clonal cell lines over a period of 4-6 weeks.
Transfection analysis
Cells were analysed for EGFP or dsRed reporter gene expression by flow cytometry using a LSR II flow cytometer (Becton Dickson, Franklin Lakes, CA, USA). Propidium iodide was added to the cell suspension prior to analysis to assess cell viability. Gating was performed on live cells. Data acquisition and analysis were performed using BD FACsDiva software (Becton Dickson).
Immunofluorescence assay
Cells transfected with 20 mg mRNA encoding Rep68 or Rep78 were cytocentrifuged onto slides using a cytospin centrifuge (Shandon Inc., Pittsburgh, PA, USA). Slides were air-dried, placed in methanol for 5 min and then permeabilized using 0.1% Triton X-100 in phosphatebuffered saline (PBS) for 5 min. The cells were then washed in three changes of PBS and fixed with 4% paraformaldehyde in PBS. After washing in three changes of PBS, cells were pre-incubated with 1% Blocking Reagent (Roche Diagnostics, Mannheim Germany) dissolved in Tris-buffered normal saline. Rep protein expression was detected using an antibody specific to both Rep68 and Rep78 proteins (American Research Products Inc. Belmont, MA, USA), followed by staining with an immunoglobulin G anti-mouse secondary antibody directly conjugated to rhodamine (Jackson ImmunoResearch Laboratories Inc., Westgrove, PA, USA). After a final wash in PBS, slides were mounted in Vectashield (Vector Laboratories, Burlingame, CA, USA) containing 4,6-diamidino-2-phenylindole (DAPI) (500 ng ml
À1
) and examined using an Olympus BX60 epifluorescence microscope. Images were captured using Cytovision software (Applied Imaging, San Jose, CA, USA).
Fluorescence in situ hybridization
Metaphase spreads were prepared according to a standard procedure. Briefly, 2-4 Â 10 6 cells were cultured in the presence of 100 ng ml À1 colcemid (Gibco BRL, Gaithersburg, MD, USA) for 1 h. Cells were then harvested and incubated in hypotonic solution (0.56% KCl) for 10 min. Cells were fixed with a 3:1 methanol: acetic acid solution and left for at least 12 h at -20 1C before dropped onto slides. The BAC transgene DNA was labelled with Spectrum Red-dUTP (Vysis, Downers Grove, IL, USA), and plasmid DNA from a human BAC clone (RP11-463M24) containing the AAVS1 site and surrounding sequences was labelled with Spectrum Green-dUTP (Vysis), using nick translation according to the manufacturer's recommendation (Vysis). The labelled DNA probes, together with human Cot1, were alcohol precipitated and resuspended in hybridization buffer (50% formamide; 10% dextran sulfate; 2 Â sodium chloride, sodium citrate buffer (SSC)) with a resulting DNA concentration of 30 ng ml
À1
. The probes were denatured by heating to 72 1C for 8 min. Slides were denatured in 70% formamide; 30% 2 Â SSC at 70 1C for 2 min, dehydrated through an ethanol series, and 2 ml of probe added beneath a 10 mm coverslip. After hybridization overnight at 37 1C the slides were washed in 1 Â SSC at 70 1C for 10 min. The slides were mounted and examined as described above. In the fibre FISH experiments, chromatin fibres were prepared according to the method described by Blower et al. 45 Cells were harvested and suspended in 0.56% KCl at a final concentration of 1 Â 10 5 cells per ml. Cells were centrifuged onto slides using a cytospin centrifuge (Shandon Inc.). Slides were placed into a buffered lysis solution (25 mM Tris, 0.5 M NaCl, 0.5 M urea, 1% Triton X-100) for 15 min at room temperature and carefully removed vertically from the buffer before being fixed in 4% buffered paraformaldehyde/PBS for 5 min. Slides were washed in PBS before being placed into fixative (1:3 acetic/methanol) for 10 min. After air-drying the slides were denatured in 70% formamide/30% 2 Â SSC at 80 1C for 6 min. Slides and probe were then treated as for using standard FISH methodology as already described.
Southern blot analysis
The long-range integrity of the b-globin transgene was examined by Southern blot analysis after the digestion of chromosomal DNA with the SfiI restriction endonuclease. To avoid shearing of genomic DNA, cells were suspended at a concentration of 5 Â 10 6 cells per ml in 0.8% InCert agarose (FMC BioProducts, Rockland, ME, USA). The solidified plugs were incubated overnight in proteinase K buffer (100 mM EDTA at pH 8.0, 0.2% sodium deoxycholate, 1% sodium lauryl sarcosine with 0.4 mg ml À1 of proteinase K) at 50 1C. The plugs were then washed three times with 2 mM phenylmethylsulphonylfluoride and stored in Tris-EDTA (TE) buffer at 4 1C. The DNA plugs were digested overnight with SfiI and loaded into the wells of a 0.8% agarose gel. The genomic DNA was then separated in a CHEF-DRII pulsed-field gel electrophoresis apparatus (Bio-Rad). The gel was subsequently incubated in depurination buffer (0.25 M HCl) for 10 min followed by 30 min incubation in denaturation buffer (1.5 M NaCl, 0.5 M NaOH). After rinsing in dH 2 O the gel was incubated in neutralization Targeted integration of the full-length b-locus SE Howden et al buffer (0.5 M Tris, 1.5 M NaCl) for a further 30 min. The DNA was then blotted onto a HybondN+ membrane (Amersham, Piscataway, NJ, USA) by capillary transfer in 20 Â SSC. A 598 bp probe specific for the EGFP gene was generated by PCR (using primers 5 0 -CTACCG GACTCAGATGATCCA-3 0 and 5 0 -TACTTGTACAGCTC GTCCATG-3 0 ) and labelled with 32 P-labelled using the Radprime DNA labelling system (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's recommendations. Hybridization was performed at 65 1C overnight in Church buffer (0.5 M Na 2 HPO 4 , 1 mM EDTA, 7% (w/v) SDS, 1% bovine serum albumin) using 32 P-labeled probes at a concentration of three million c.p.m. ml À1 .
